Clinical Trial Update: Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating how the investigational compound NNC0487-0111 regulates insulin in adults with Type 2 diabetes, and the study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus | Phase 1 | Status: RECRUITING